Healthcare Data Integration Will Broaden Future Addressable Markets

AnalystConsensusTarget

Not Invested

Consensus Narrative from 9 Analysts

Published

11 May 25

Updated

08 Aug 25

AnalystConsensusTarget's Fair Value

US$4.10

5.9% undervalued

08 Aug

US$3.86

-0.8%

3.2%

Author's Valuation

US$4.1

5.9% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates0

AnalystConsensusTarget Fair Value

US$4.1

5.9% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

-0.40%

Healthtech revenue growth rate

4.69%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

8.62%

Calculation

US$90.88m

Earnings '28

4.98x

PE Ratio '28

US$452.82m

Market Cap '28

US$452.82m

Market Cap '28

86.34m

No. shares '28

US$5.24

Share Price '28

US$5.24 Share Price '28

Discounted to 2025 @ 8.56% p.a.

US$4.10

Fair Value '25